ELVN · Forms 3, 4, 5
Insider trades at Enliven Therapeutics, Inc.
1 insider sold $607K of Enliven Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Enliven Therapeutics, Inc. (ELVN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kristine M Ball | Director | Options or other derivatives | Form 4 | ||||
| Kristine M Ball | Director | Became an insider (Form 3) | Form 3 | ||||
| J. Scott Garland | Director | Option exercise | 13,000 | $15.47 | $201K | Form 4 | |
| J. Scott Garland | Director | Sell | 13,000 | $46.67 | $607K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Option exercise | 3,982 | $14.85 | $59K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 3,535 | $50.03 | $177K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 2,194 | $50.72 | $111K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 289 | $51.49 | $15K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Option exercise | 5,000 | $2.48 | $12K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 2,916 | $50.03 | $146K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 1,844 | $50.71 | $94K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 240 | $51.48 | $12K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 4,630 | $58.35 | $270K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 1,388 | $59.35 | $82K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Option exercise | 5,000 | $2.48 | $12K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 3,900 | $58.37 | $228K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 1,100 | $59.35 | $65K | Form 4 | |
| Mika K Derynck | Director | Option exercise | 87,373 | $2.48 | $217K | Form 4 | |
| Mika K Derynck | Director | Option exercise | 27,567 | $25.28 | $697K | Form 4 | |
| Mika K Derynck | Director | Option exercise | 23,364 | $14.85 | $347K | Form 4 | |
| Mika K Derynck | Director | Option exercise | 20,491 | $22.47 | $460K | Form 4 | |
| Mika K Derynck | Director | Sell | 158,795 | $60.21 | $9.6M | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Option exercise | 1,072 | $2.48 | $3K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 324 | $49.97 | $16K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 369 | $51.48 | $19K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 2,564 | $52.32 | $134K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 2,638 | $53.38 | $141K | Form 4 | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sell | 123 | $53.87 | $7K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Option exercise | 5,000 | $2.48 | $12K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 231 | $50.05 | $12K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 459 | $51.55 | $24K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 2,063 | $52.39 | $108K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 2,184 | $53.42 | $117K | Form 4 | |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | Sell | 63 | $53.92 | $3K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.